INTERNATIONAL SOC FOR HEMODIALYSIS

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

CHRISTOPHER CHAN MD

Phone

7733439699

Tax Period

2021-01-01 to 2021-12-31

INTERNATIONAL SOC FOR HEMODIALYSIS, founded in 2000, is a micro nonprofit in the Medical Research sector that reported $71K in total revenue in fiscal year 2021. Revenue surged 134% from the prior year, signaling strong growth momentum. Expenses of $67K left a modest 6% surplus.

Mission

ORGANIZED TO IMPROVE CARE OF THE RENAL FAILURE PATIENT, TO UPGRADE DIALYSIS TEACHING, TO PROMOTE DIALYSIS RESEARCH, AND TO DISSEMINATE KNOWLEDGE.

Program Service Accomplishments

Program 1

Expenses: $45,354 Revenue: $71,119

MEETINGS AND EXHIBITS FOR NEPHROLOGISTS, NEPHROLOGY TRAINEES, NURSES, TECHNOLOGISTS, AND SOCIAL WORKERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $301

Program Service Revenue $71,119

Investment Income $0

Other Revenue $0

TOTAL REVENUE $71,420

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $45,354

Other Expenses $67,474

TOTAL EXPENSES $67,474

Year-over-Year Comparison

	2021	2020	Change
Revenue	$71,420	$30,475	+1.3%
Expenses	$67,474	$62,063	+0.1%
Net Income	$3,946	$-31,588	-1.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BERNARD CANUAD MD	SECRETARY	N/A	Officer	$0	$0	$0
JOHN BALL MD	TREASURER	N/A	Officer	$0	$0	$0
VICTOR GURA MD	DIRECTOR	N/A	Director	$0	$0	$0
MITCHELL ROSNER MD	DIRECTOR	N/A	Director	$0	$0	$0
X Q DING MD	DIRECTOR	N/A	Director	$0	$0	$0
ZAKI MORAD MD	DIRECTOR	N/A	Director	$0	$0	$0
CARLOS BLANCO MD	DIRECTOR	N/A	Director	$0	$0	$0
CONNIE ANDERSON	DIRECTOR	N/A	Director	$0	$0	$0
ELIZABETH LINDLEY	DIRECTOR	N/A	Director	$0	$0	$0
CHRISTOPHER CHAN MD	PRESIDENT	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2021	$71,420	$67,474	$68,748	$3,946
2020	$30,475	$62,063	$64,803	$-31,588
2019	$243,521	$206,690	$96,391	$36,831
2018	$59,643	$138,042	$59,559	$-78,399